Introduction
The structural evolution of biological tissues over time results from the interaction of multiple processes regulating tissue turnover, repair, and mechanical adaptation. In the craniofacial region, aging has traditionally been interpreted as a consequence of gravity, tissue degeneration, or collagen breakdown. However, increasing evidence suggests that the dominant structural mechanism underlying aging is tissue atrophy, affecting bone, adipose tissue, connective structures, and skin.
At the same time, tissues possess intrinsic mechanisms that respond to injury or mechanical stress by reinforcing structural integrity. One of the most important of these mechanisms is fibrosis, characterized by fibroblast activation and deposition of extracellular matrix components such as collagen and fibronectin.
Within the framework of the Morphodynamic Theory of Aging, tissue aging can therefore be interpreted as the result of a dynamic interaction between two opposing processes: atrophy and fibrosis. While atrophy reduces tissue density and structural support, fibrosis contributes to structural reinforcement and mechanical stabilization.
This conceptual framework may be defined as the Atrophy–Fibrosis Balance Model of Tissue Aging, in which the structural state of tissues is determined by the balance between degenerative and reparative processes.
Atrophy as the Dominant Mechanism of Aging
Atrophy represents the primary biological driver of tissue aging. It is characterized by a progressive reduction in tissue mass, cellular activity, and extracellular matrix density.
In the craniofacial region, atrophy affects multiple anatomical layers:
- bone tissue, through progressive resorption and remodeling
- adipose compartments, through volume loss and redistribution
- dermal connective tissue, through reduced collagen synthesis and fibroblast activity
- muscular structures, through age-related sarcopenia
Craniofacial studies have demonstrated that the facial skeleton continues to undergo structural remodeling during adulthood, including enlargement of the orbital aperture, retrusion of the maxilla, and mandibular resorption (Shaw & Kahn, 2007; Mendelson & Wong, 2012). These skeletal changes reduce the structural support of overlying soft tissues.
At the same time, dermal aging is associated with decreased collagen production and fragmentation of extracellular matrix components, leading to reduced tissue elasticity and mechanical strength (Ciarletta, 2012).
The visible manifestations of these processes include:
- loss of tissue firmness
- increased skin laxity
- reduction of facial volume
From a morphodynamic perspective, aging is therefore primarily interpreted as a progressive atrophic process leading to structural weakening of tissues.
Fibrosis as a Reparative Structural Response
Fibrosis is frequently described in the medical literature as a pathological process associated with chronic disease. However, in its physiological form, fibrosis represents a fundamental tissue repair mechanism.
When tissues are subjected to injury or mechanical stress, fibroblasts become activated and initiate the synthesis of extracellular matrix components. This response increases connective tissue density and temporarily reinforces structural integrity.
Fibrotic remodeling plays an essential role in several biological processes, including wound healing, scar formation, and connective tissue repair (Wynn & Ramalingam, 2012).
Importantly, fibrotic responses are not limited to aging tissues. In fact, younger individuals often exhibit stronger fibrotic responses, reflecting greater fibroblast activity and regenerative capacity. An example of this phenomenon is the formation of keloids, which occur more frequently in young individuals and are characterized by excessive collagen deposition.
From a structural perspective, fibrosis therefore acts as a counterbalancing mechanism to tissue atrophy, increasing extracellular matrix deposition and improving mechanical stability.
Structural Equilibrium and Tissue Mechanics
Healthy tissues exist in a state of dynamic structural equilibrium, in which tissue turnover, mechanical forces, and repair processes remain balanced.
Within this equilibrium:
- extracellular matrix synthesis and degradation are regulated
- fibroblast activity maintains tissue architecture
- mechanical forces influence structural adaptation
Mechanobiology studies have demonstrated that mechanical stimuli regulate fibroblast activity and extracellular matrix production through mechanotransduction pathways (Martino et al., 2018; Vining & Mooney, 2017).
With aging, regenerative capacity declines and the equilibrium gradually shifts toward atrophy and structural weakening. However, localized fibrotic responses may still occur in response to mechanical stimulation or tissue injury.
The structural condition of tissues may therefore be interpreted as the result of the relative predominance of atrophy or fibrosis.
Controlled Fibrosis in Aesthetic Medicine
The Atrophy–Fibrosis Balance Model has important implications for regenerative and aesthetic medicine.
Many aesthetic treatments aim to stimulate controlled fibrotic remodeling, increasing connective tissue density and restoring tissue firmness. These treatments include:
- radiofrequency-based devices
- focused ultrasound stimulation
- suspension threads
- biostimulatory dermal fillers
- calcium hydroxylapatite-based treatments
Although these technologies operate through different mechanisms, they share a common biological objective: to activate fibroblasts and promote moderate extracellular matrix deposition.
This controlled fibrotic response increases dermal density and partially compensates for the structural weakening caused by atrophy.
Thus, fibrosis in aesthetic medicine should be interpreted not as a pathological phenomenon but as a therapeutic mechanism of structural reinforcement.
Pathological Fibrosis and Structural Imbalance
While moderate fibrosis may contribute to tissue reinforcement, excessive fibrotic responses can become pathological.
Pathological fibrosis is characterized by:
- excessive collagen deposition
- abnormal tissue stiffening
- disruption of normal tissue architecture
Examples include hypertrophic scars, keloids, and organ fibrosis.
These conditions represent a disruption of the normal structural equilibrium, in which fibrotic activity exceeds physiological limits (Wynn & Ramalingam, 2012).
Within the Atrophy–Fibrosis Balance Model, such conditions occupy the opposite extreme of the structural spectrum from atrophy-driven tissue degeneration.
Conceptual Model: The Atrophy–Fibrosis Balance
The structural state of biological tissues can be conceptualized along a continuum defined by the relative predominance of atrophy and fibrosis.
Figure X. The Atrophy–Fibrosis Balance Model of Tissue Aging
The diagram illustrates three functional zones:
- Atrophy-dominant zone
Characterized by loss of tissue density, structural weakening, and laxity.
Typical of aging tissues. - Balanced structural zone
Characterized by equilibrium between extracellular matrix turnover and controlled repair.
Associated with optimal tissue mechanics and structural integrity. - Fibrosis-dominant zone
Characterized by excessive extracellular matrix accumulation and tissue stiffening.
Associated with pathological fibrosis such as keloids or organ fibrosis.
This model emphasizes that both extremes—severe atrophy and excessive fibrosis—represent deviations from physiological equilibrium.
Conclusion
The Atrophy–Fibrosis Balance Model of Tissue Aging provides a conceptual framework for understanding the structural dynamics of tissues over time.
Aging is primarily driven by atrophy, leading to progressive loss of tissue density and mechanical support. Fibrosis, in contrast, represents a reparative structural response capable of reinforcing connective tissues.
When properly regulated, fibrotic remodeling contributes to maintaining tissue firmness and structural integrity. When excessive, however, fibrosis becomes pathological.
Recognizing the dynamic balance between these processes is particularly relevant for regenerative and aesthetic medicine, where therapeutic strategies increasingly aim to stimulate controlled fibrotic responses in order to restore structural support in aging tissues.
References
Ciarletta, P. (2012). On the biomechanics and mechanobiology of growing skin. Journal of Theoretical Biology, 297, 166-175.
Martino, F., Perestrelo, A., Vinarský, V., Pagliari, S., & Forte, G. (2018). Cellular mechanotransduction: From tension to function. Frontiers in Physiology, 9, 824.
Mendelson, B., & Wong, C. H. (2012). Changes in the facial skeleton with aging: Implications and clinical applications in facial rejuvenation. Aesthetic Plastic Surgery, 36, 753-760.
Shaw, R. B., & Kahn, D. M. (2007). Aging of the facial skeleton: Aesthetic implications and rejuvenation strategies. Plastic and Reconstructive Surgery, 119, 675-682.
Vining, K. H., & Mooney, D. J. (2017). Mechanical forces direct stem cell behaviour in development and regeneration. Nature Reviews Molecular Cell Biology, 18, 728-742.
Wynn, T. A., & Ramalingam, T. R. (2012). Mechanisms of fibrosis: Therapeutic translation for fibrotic disease. Nature Medicine, 18, 1028-1040.
